Use of ribofuranose derivatives against inflammatory bowel diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6930093
APP PUB NO 20050009766A1
SERIAL NO

10618148

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for the prophylaxis or treatment of an inflammatory bowel disease is provided, comprising administering to a patient having or at risk of developing an inflammatory bowel disease a therapeutically or preventatively effective amount of one or more ribofuranose derivatives having the Formula (I): ##STR1##

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RIBAPHARM PHARMACEUTICALS3300 HYLAND AVENUE COSTA MESA CA 92626

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brantl, Victor Schliengen, DE 14 69

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation